Cox & Kings EBITDA margin
Was ist das EBITDA margin von Cox & Kings?
EBITDA margin von Cox & Kings Limited ist -11,428.57%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Consumer Discretionary Sektor auf NSE im Vergleich zu Cox & Kings
Was macht Cox & Kings?
Cox & Kings Limited provides tours and travel services worldwide. It primarily offers destination management, outbound tourism, business travel, incentive and conference solutions, domestic holidays, and trade fairs services. The company was formerly known as Cox and Kings (India) Limited and changed its name to Cox & Kings Limited in July 2010. Cox & Kings Limited was founded in 1758 and is based in Mumbai, India.
Unternehmen mit ebitda margin ähnlich Cox & Kings
- Kaleido Biosciences Inc hat EBITDA margin von -11,658.74%
- Predictiv AI hat EBITDA margin von -11,506.76%
- Internet of Things hat EBITDA margin von -11,506.76%
- Perk Labs hat EBITDA margin von -11,490.40%
- Albion Resources Ltd hat EBITDA margin von -11,464.10%
- Calyxt Inc hat EBITDA margin von -11,433.53%
- Cox & Kings hat EBITDA margin von -11,428.57%
- Clene Nanomedicine hat EBITDA margin von -11,425.57%
- Talga Resources hat EBITDA margin von -11,365.21%
- China New Economy Fund hat EBITDA margin von -11,353.08%
- genedrive plc hat EBITDA margin von -11,330.61%
- Centaurus Metals hat EBITDA margin von -11,291.14%
- Acasti Pharma hat EBITDA margin von -11,186.96%